Management of HBV in Liver Transplant Patients


Transplant in the Setting of Fulminant Hepatic Failure from HBV (including HDV coinfection)

Tuesday, May 17, 2022, 9:00 AM (Local time in Montreal)
Local time (Corresponding local time at your current location)
The duration of this presentation is scheduled for 60 minutes.

Overview

Objectives of the case-based presentations are the discussion of risk factors and diagnostic approaches of fulminant hepatic failure from hepatitis B, along with acute management, including progression to liver transplant. Peri- and post-transplant management including antivirals, immunoglobulins and other therapeutic modalities will be covered. Patient management globally and within the respective regions of the physicians, best practice sharing as well as local and international guidelines will be further topics.
Moderator
Camille Kotton
USA
Bio
Speaker
Peter Schemmer
Austria
Bio
Speaker
Marina Berenguer
Spain
Bio
Speaker
Anna Lok
USA
Bio

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada